The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Ezetimibe therapy: mechanism of action and clinical update
Open accessAbstract
The lowering of low-density lipoprotein cholesterol (LDL-C) is the primary target of therapy in the primary and secondary prevention of cardiovascular events. Although statin therapy is the mainstay for LDL-C lowering, a significant percentage of patients prescribed these agents either do not achieve targets with statin therapy alone or have partial or complete intolerance to them. For such patients, the use of adjuvant therapy capable of providing incremental LDL-C reduction is advised. One such agent is ezetimibe, a cholesterol absorption inhibitor that targets uptake at the jejunal enterocyte brush border. Its primary target of action is the cholesterol transport protein Nieman Pick C1 like 1 protein. Ezetimibe is an effective LDL-C lowering agent and is safe and well tolerated. In response to significant controversy surrounding the use and therapeutic effectiveness of this drug, we provide an update on the biochemical mechanism of action for ezetimibe, its safety and efficacy, as well as the results of recent randomized studies that support its use in a variety of clinical scenarios.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Smart, E. J., Rose, R. A. D., & Farber, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400441101 · Cited by 133
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804602 · Cited by 1,644
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,577
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
KANNEL, W. B., CASTELLI, W. P., & GORDON, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,311
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Kastelein, J. J. P., Akdim, F., Stroes, E. S. G., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F. H., Visseren, F. L. J., Sijbrands, E. J. G., Trip, M. D., Stein, E. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800742 · Cited by 1,241
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,093
Pearson, T. A., Laurora, I., Chu, H., & Kafonek, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.459 · Cited by 1,012
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001
Smilde, T., van Wissen, S., Awollersheim, H., Trip, M., Kastelein, J., & Stalenhoef, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04053-8 · Cited by 918
Taylor, A. J., Sullenberger, L. E., Lee, H. J., Lee, J. K., & Grace, K. A. (2004) · Circulation · doi:10.1161/01.cir.0000148955.19792.8d · Cited by 890
Dietschy, J., Turley, S., & Spady, D. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35728-x · Cited by 874
Iqbal, J., & Hussain, M. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90899.2008 · Cited by 811
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Cannon, C. P., Steinberg, B. A., Murphy, S. A., Mega, J. L., & Braunwald, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.070 · Cited by 770
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)
Garcia-Calvo, M., Lisnock, J., Bull, H. G., Hawes, B. E., Burnett, D. A., Braun, M. P., Crona, J. H., Davis, H. R., Dean, D. C., Detmers, P. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500269102 · Cited by 670
Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
Taylor, A. J., Villines, T. C., Stanek, E. J., Devine, P. J., Griffen, L., Miller, M., Weissman, N. J., & Turco, M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907569 · Cited by 644
Mechanisms of disease: genetic causes of familial hypercholesterolemia
Soutar, A. K., & Naoumova, R. P. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0836 · Cited by 608
Yu, L., Li-Hawkins, J., Hammer, R. E., Berge, K. E., Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216001 · Cited by 596
The seven countries study: 2,289 deaths in 15 years
Keys, A., Menotti, A., Aravanis, C., Blackburn, H., Djordevič, B. S., Buzina, R., Dontas, A. S., Fidanza, F., Karvonen, M. J., Kimura, N., et al. (1984) · Preventive Medicine · doi:10.1016/0091-7435(84)90047-1 · Cited by 553
Gagné, C., Bays, H. E., Weiss, S. R., Mata, P., Quinto, K., Melino, M., Cho, M., Musliner, T. A., & Gumbiner, B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02774-1 · Cited by 495
Safety considerations with fibrate therapy
Davidson, M. H., Armani, A., McKenney, J. M., & Jacobson, T. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.016 · Cited by 408
Cohen, J. C., Pertsemlidis, A., Fahmi, S., Esmail, S., Vega, G. L., Grundy, S. M., & Hobbs, H. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508483103 · Cited by 378
Ge, L., Wang, J., Qi, W., Miao, H.-H., Cao, J., Qu, Y.-X., Li, B.-L., & Song, B.-L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.001 · Cited by 375
Temel, R. E., Tang, W., Ma, Y., Rudel, L. L., Willingham, M. C., Ioannou, Y. A., Davies, J. P., Nilsson, L.-M., & Yu, L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30060 · Cited by 369
Robinson, J. G., Wang, S., Smith, B. J., & Jacobson, T. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.024 · Cited by 368
Rosenblum, S. B., Huynh, T., Afonso, A., Davis, H. R., Yumibe, N., Clader, J. W., & Burnett, D. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970701f · Cited by 361
Van Heek, M., Farley, C., Compton, D. S., Hoos, L., Alton, K. B., Sybertz, E. J., & Davis, H. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703235 · Cited by 326
Waters, D. D., Brotons, C., Chiang, C.-W., Ferrières, J., Foody, J., Jukema, J. W., Santos, R. D., Verdejo, J., Messig, M., McPherson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.838466 · Cited by 306
Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia
Salen, G., von Bergmann, K., Lütjohann, D., Kwiterovich, P., Kane, J., Patel, S. B., Musliner, T., Stein, P., Musser, B., & the Multicenter Sitosterolemia Study Group (2004) · Circulation · doi:10.1161/01.cir.0000116766.31036.03 · Cited by 304
Cannon, C. P., Giugliano, R. P., Blazing, M. A., Harrington, R. A., Peterson, J. L., Sisk, C. M., Strony, J., Musliner, T. A., McCabe, C. H., Veltri, E., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.023 · Cited by 299
Direct Binding of Cholesterol to the Purified Membrane Region of SCAP
Radhakrishnan, A., Sun, L.-P., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.019 · Cited by 295
Statin use and cancer risk: a comprehensive review
Boudreau, D. M., Yu, O., & Johnson, J. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740331003662620 · Cited by 274
Safety considerations with niacin therapy
Guyton, J. R., & Bays, H. E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.018 · Cited by 269
Morrone, D., Weintraub, W. S., Toth, P. P., Hanson, M. E., Lowe, R. S., Lin, J., Shah, A. K., & Tershakovec, A. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.016 · Cited by 263
Self-citationEffect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes
Fleg, J. L., Mete, M., Howard, B. V., Umans, J. G., Roman, M. J., Ratner, R. E., Silverman, A., Galloway, J. M., Henderson, J. A., Weir, M. R., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.031 · Cited by 245
Howard, B. V. (2008) · JAMA · doi:10.1001/jama.299.14.1678 · Cited by 241
Mechanisms for cellular cholesterol transport: Defects and human disease
Ikonen, E. (2006) · Physiological Reviews · doi:10.1152/physrev.00022.2005 · Cited by 229
Pandor, A., Ara, R. M., Tumur, I., Wilkinson, A. J., Paisley, S., Duenas, A., Durrington, P. N., & Chilcott, J. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02062.x · Cited by 228
Analyses of Cancer Data from Three Ezetimibe Trials
Peto, R., Emberson, J., Landray, M., Baigent, C., Collins, R., Clare, R., & Califf, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0806603 · Cited by 228
Genetic basis of sitosterolemia
Lee, M.-H., Lu, K., & Patel, S. B. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00007 · Cited by 196
Pharmacotherapy for dyslipidaemia – current therapies and future agents
Bays, H., & Stein, E. A. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.1901 · Cited by 172
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
LaRosa, J. C., Grundy, S. M., & Waters, D. D. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.10.023 · Cited by 163
Emerging roles of the intestine in control of cholesterol metabolism
Kruit, J. K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i40.6429 · Cited by 160
Ghosal, A., Hapangama, N., Yuan, Y., Achanfuo-Yeboah, J., Iannucci, R., Chowdhury, S. K., Alton, K. B., Patrick, J. E., & Zbáida, S. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.314 · Cited by 143
van Heek, M., Compton, D. S., & Davis, H. R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00825-1 · Cited by 131
Goldberg, R. B., Guyton, J. R., Mazzone, T., Weinstock, R. S., Polis, A. B., Edwards, P., Tomassini, J. E., & Tershakovec, A. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.12.1579 · Cited by 128
Simon, J. S., Karnoub, M., Devlin, D. J., Arreaza, M. G., Qiu, P., Monks, S. A., Severino, M. E., Deutsch, P., Palmisano, J. J., Sachs, A. B., et al. (2005) · Genomics · doi:10.1016/j.ygeno.2005.08.007 · Cited by 127
Kramer, W., Girbig, F., Corsiero, D., Pfenninger, A., Frick, W., Jähne, G., Rhein, M., Wendler, W., Lottspeich, F., Hochleitner, E. O., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406309200 · Cited by 124
Clathrin coat construction in endocytosis
Pearse, B. M. F. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00071-3 · Cited by 120
Extracellular loop C of NPC1L1 is important for binding to ezetimibe
Weinglass, A. B., Köhler, M. G., Schulte, U., Liu, J., Nketiah, E. O., Thomas, A., Schmalhofer, W. A., Williams, B. S., Bildl, W., McMasters, D. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800936105 · Cited by 117
Santosa, S., Varady, K. A., AbuMweis, S. S., & Jones, P. J. H. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.10.006 · Cited by 109
Kashani, A., Sallam, T., Bheemreddy, S., Mann, D. L., Wang, Y., & Foody, J. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.041 · Cited by 107
Bays, H. E. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.11.1587 · Cited by 101
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion
Huff, M. W., & Burnett, J. R. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00003 · Cited by 100
Current management of severe homozygous hypercholesterolaemias
Naoumova, R. P., Thompson, G. R., & Soutar, A. K. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137222.23784.2a · Cited by 99
Sun, W. Y., Lo, C., & Tso, P. (2008) · Textbook of Gastroenterology · doi:10.1002/9781444303254.ch18 · Cited by 96
Does ENHANCE Diminish Confidence in Lowering LDL or in Ezetimibe?
Brown, B. G., & Taylor, A. J. (2008) · New England Journal of Medicine · doi:10.1056/nejme0801608 · Cited by 95
Repa, J. J., Turley, S. D., Quan, G., & Dietschy, J. M. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400475-jlr200 · Cited by 91
Statins and Cancer Development
Duncan, R. E., El‐Sohemy, A., & Archer, M. C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0027 · Cited by 90
Califf, R. M., Lokhnygina, Y. V., Cannon, C. P., Stepanavage, M. E., McCabe, C. H., Musliner, T. A., Pasternak, R. C., Blazing, M. A., Giugliano, R. P., Harrington, R. A., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.03.004 · Cited by 88
Toth, P. P. (2012) · Yearbook of Endocrinology · doi:10.1016/j.yend.2012.05.035 · Cited by 86
Self-citationPharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor
Jeu, L., & Cheng, J. W. M. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80281-3 · Cited by 84
Current Therapy for Patients with Sitosterolemia –Effect of Ezetimibe on Plant Sterol Metabolism
Tsubakio‐Yamamoto, K., Nishida, M., Nakagawa-Toyama, Y., Masuda, D., Ohama, T., & Yamashita, S. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4614 · Cited by 84
Intensive versus moderate lipid lowering with statins after acute coronary syndromes*
(2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000133105.83326.47 · Cited by 80
Davis, H. R., Pula, K. K., Alton, K. B., Burrier, R. E., & Watkins, R. W. (2001) · Metabolism · doi:10.1053/meta.2001.26737 · Cited by 79
Gazi, I. F., Daskalopoulou, S. S., Nair, D. R., & Mikhailidis, D. P. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226267 · Cited by 79
The Vytorin on Carotid Intima‐Media Thickness and Overall Arterial Rigidity (VYCTOR) Study
Meaney, A., Ceballos, G. M., Asbún, J., Solache, G., Mendoza, E., Vela, A., & Meaney, E. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337011 · Cited by 78
Lütjohann, D., von Bergmann, K., Sirah, W., Macdonell, G., Johnson‐Levonas, A. O., Shah, A. K., Lin, J., Sapre, A., & Musliner, T. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01841.x · Cited by 67
Severe Hepatic Side Effects of Ezetimibe
Stolk, M. F. J., Becx, M. C., Kuypers, K. C., & Seldenrijk, C. A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.04.014 · Cited by 65
Robinson, J. G., Ballantyne, C. M., Grundy, S. M., Hsueh, W. A., Parving, H., Rosen, J. B., Adewale, A. J., Polis, A. B., Tomassini, J. E., & Tershakovec, A. M. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.003 · Cited by 64
Holme, I., Boman, K., Brudi, P., Egstrup, K., Gohlke-Baerwolf, C., Kesäniemi, Y. A., Malbecq, W., Rossebø, A. B., Wachtell, K., Willenheimer, R. B., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.363 · Cited by 62
Brown, W. V. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328319baba · Cited by 61
Salen, G., Patel, S. K., & Batta, A. K. (2002) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2002.tb00096.x · Cited by 55
Taylor, A., Sullenberger, L., Lee, H., Lee, J., & Grace, K. A. (2008) · The Physician and Sportsmedicine · doi:10.3810/psm.2008.12.22 · Cited by 51
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
Hamilton-Craig (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s13496 · Cited by 49
Cholesterol homeostasis by the intestine: Lessons from Niemann-Pick C1 Like 1 [NPC1L1)
Davis, H. R., Basso, F., Hoos, L. M., Tetzloff, G. G., Lally, S. M., & Altmann, S. W. (2008) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2008.05.008 · Cited by 46
CHOLESTERYL ESTER TRANSFER PROTEIN: ITS ROLE IN PLASMA LIPID TRANSPORT
Barter, P. J., & Rye, K. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02569.x · Cited by 43
Statin Therapy with Ezetimibe or Niacin in High-Risk Patients
Kastelein, J. J. P., & Bots, M. L. (2009) · New England Journal of Medicine · doi:10.1056/nejme0908841 · Cited by 41
Perspectives on low-density-lipoprotein cholesterol goal achievement
Catapano, A. L. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802631438 · Cited by 40
Winkler, K., Jacob, S., Schewe, T., Hoffmann, M. M., & Konrad, T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.043 · Cited by 40
Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years
Lioudaki, E., Ganotakis, E. S., & Mikhailidis, D. P. (2010) · Current Vascular Pharmacology · doi:10.2174/157016111793744760 · Cited by 40
A practical approach to the metabolic syndrome: review of current concepts and management
Tota-Maharaj, R., DeFilippis, A. P., Blumenthal, R. S., & Blaha, M. J. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32833cd474 · Cited by 35
Atorvastatin in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis
Wanner, C., Krane, V., & März, W. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.09.027 · Cited by 35
The HALTS Trial — Halting Atherosclerosis or Halted Too Early?
Blumenthal, R. S., & Michos, E. D. (2009) · New England Journal of Medicine · doi:10.1056/nejme0908838 · Cited by 34
Simvastatin With or Without Ezetimibe in Familial Hypercholesterolemia
Chen, L. (2008) · Journal of Evidence-Based Medicine · Cited by 31
Simvastatin‐Ezetimibe‐Induced Hepatic Failure Necessitating Liver Transplantation
Tuteja, S., Pyrsopoulos, N., Wolowich, W. R., Khanmoradi, K., Levi, D., Selvaggi, G., Weisbaum, G. S., Tzakis, A. G., & Schiff, E. R. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.9.1188 · Cited by 30
Moneta, G. L. (2009) · Yearbook of Vascular Surgery · doi:10.1016/s0749-4041(09)79141-9 · Cited by 30
Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia
Burnett, J. R., & Huff, M. W. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.11.1337 · Cited by 29
Intestinal sterol transporters and cholesterol absorption inhibition
Davis, H. R., Tershakovec, A. M., Tomassini, J. E., & Musliner, T. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834c7c28 · Cited by 28
Serious drug-induced liver disease secondary to ezetimibe
Castellote, J., Ariza, J., Rota, R., Girbau, A., & Xiol, X. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5098 · Cited by 27
Scarpioni, R., Ricardi, M., Melfa, L., & Cristinelli, L. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00182.x · Cited by 24
Stein, E. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.002 · Cited by 24
Waters, D. D., Brotons, C., & Chiang, C. W. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.11.067 · Cited by 23
Analyses of Cancer Data from Three Ezetimibe Trials
Nissen, S. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmc082188 · Cited by 21
Rationale, design and methods of the CASHMERE study†
Simon, T., Boutouyrie, P., Gompel, A., Christin‐Maître, S., Laurent, S., Thuillez, C., Zannad, F. M., Bernaud, C., Jaillon, P., & on behalf of the CASHMERE investigators (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2003.00233.x · Cited by 20
High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe
Dietrich, T., Hucko, T., Bourayou, R., Jahnke, C., Paetsch, I., Atrott, K., Stawowy, P., Gräfe, M., Klein, C., Schnackenburg, B., et al. (2009) · International journal of cardiac imaging · doi:10.1007/s10554-009-9487-5 · Cited by 19
Howard, B. V., Roman, M. J., Devereux, R. B., Fleg, J. L., Galloway, J. M., Henderson, J. A., Howard, W. J., Lee, E. T., Méte, M., Poolaw, B., et al. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000320471.93857.21 · Cited by 19
Toth, P. P., & Maki, K. C. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.06.011 · Cited by 19
Self-citationGuyton, J. R. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833c1f16 · Cited by 16
Moneta, G. L. (2010) · Yearbook of Vascular Surgery · doi:10.1016/s0749-4041(09)79256-5 · Cited by 15
Pitsavos, C. S., Skoumas, I., Tousoulis, D., Metallinos, G., Masoura, C., Chrysohoou, C. A., Papadimitriou, L., Giotsas, N., Toutouza, M., Antoniades, C. A., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.065 · Cited by 14
Effect of Ezetimibe on Remnant-Like Particle Cholesterol in Subjects with Metabolic Syndrome
Kotani, K., Sakane, N., & Taniguchi, N. (2011) · Medical Principles and Practice · doi:10.1159/000332436 · Cited by 9
Catapano, A. L. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00534.x · Cited by 6
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538
Decreased Endogenous Production of Hydrogen Sulfide Accelerates Atherosclerosis
Mani, S., Li, H., Untereiner, A., Wu, L., Yang, G., Austin, R. C., Dickhout, J. G., Lhoták, Š., Meng, Q. H., & Wang, R. (2013) · Circulation · doi:10.1161/circulationaha.113.002208 · Cited by 377
Metadata
- Authors
- Toth, P., Phan, & Dayspring, T.
- Venue
- Vascular Health and Risk Management
- Publisher
- Informa UK Limited
- Published
- 2012-07
- Volume
- 8
- Pages
- 415
- ISSN
- 1176-6344 (ISSN-L)
- 1178-2048
- OpenAlex
- W1989042353
- Cited by
- 288
- References
- 125
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.